Beverage consumption patterns of children born at different risk of obesity

Tanja V E Kral1, Albert J Stunkard, Robert I Berkowitz

  • 1Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA. tkral@mail.med.upenn.edu

Insights

Children at high risk for obesity consumed more sugary drinks and fruit juice. Increased soda intake was linked to larger waist circumference, while milk intake was linked to reduced waist circumference in children.

Area of Science:

  • Pediatric nutrition
  • Obesity research
  • Childhood health

Background:

  • Increased sugar-sweetened beverage and fruit juice intake is linked to childhood overweight.
  • Understanding beverage consumption in children at risk for obesity is crucial.

Purpose of the Study:

  • To prospectively assess beverage consumption patterns in children.
  • To examine the relationship between beverage intake and weight status in children with varying obesity risk.

Main Methods:

  • Cohort study of children (n=49) stratified by obesity risk (maternal BMI).
  • 3-day food records analyzed beverage intake (milk, juice, soda, etc.) in children aged 3-6 years.
  • Yearly anthropometric measurements collected.

Main Results:

  • High-risk children consumed more calories from beverages, fruit juice, and soft drinks.
  • Increased soda intake correlated with increased waist circumference change.
  • Increased milk intake correlated with reduced waist circumference change.
  • No significant association found between beverage intake changes and BMI z-score changes.

Conclusions:

  • Familial predisposition to obesity may influence children's beverage choices.
  • Dietary factors warrant further investigation for their role in pediatric body fat accumulation.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...